Roche's Alzheimer's drug fails to meet goal in long awaited trial - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.

The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020.The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020.

The drug was associated with a relative reduction in clinical decline of 8% in Graduate 1 and 6% in Graduate 2 compared with the placebo, but those results were not statistically reliable, the company said in a statement. The quest to develop an Alzheimer’s drug, targeting beta-amyloid or other molecules, has been beset by a long list of study failures.

Most of the 55 million people suffering from dementia worldwide are believed to be affected by Alzheimer’s disease,according to the World Health Organization. In 2030, dementia is expected to affect 78 million.Berenberg analysts have put a 50% probability on Roche achieving 10 billion Swiss francs in peak annual gantenerumab sales. Other analysts have not included the drug candidate in their group revenue estimates, due to uncertainty.

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Kimberley residents plead for security, accuse drug addicts of gravesite vandalism - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.Residents of Kimberley in the Northern Cape, accuse drugs addicts and scrap metal dealers of frequently vandalising tombstones in cemeteries across the City Also in Soshanguve they do that Jacobsa501 They should be stoped, our SA police should stop looking for some tips and catch those theives. It's out of control now
Source: SABCNews - 🏆 37. / 51 Read more »